Cronos Group Inc. (CRON.TO)
CAD 2.72
(-2.51%)
CAD 2.72
(-2.51%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -73.96 Million USD | 56.17% |
| 2022 | -168.73 Million USD | 57.47% |
| 2021 | -396.7 Million USD | -431.63% |
| 2020 | -74.62 Million USD | -103.04% |
| 2019 | 2.45 Billion CAD | 17729.39% |
| 2018 | -13.92 Million CAD | -803.1% |
| 2017 | 1.98 Million CAD | 323.73% |
| 2016 | -885.4 Thousand CAD | -418.17% |
| 2015 | 278.27 Thousand CAD | 106.7% |
| 2014 | -4.15 Million CAD | -570.01% |
| 2013 | -619.47 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -8.75 Million USD | -290.76% |
| 2024 Q1 | -2.24 Million USD | 95.0% |
| 2023 Q1 | -19.25 Million USD | 75.58% |
| 2023 FY | -73.96 Million USD | 56.17% |
| 2023 Q4 | -44.79 Million USD | -2624.45% |
| 2023 Q3 | -1.64 Million USD | 80.33% |
| 2023 Q2 | -8.36 Million USD | 56.59% |
| 2022 Q2 | -20.33 Million USD | 37.71% |
| 2022 FY | -168.73 Million USD | 57.47% |
| 2022 Q1 | -32.65 Million USD | 75.57% |
| 2022 Q4 | -78.85 Million USD | -113.79% |
| 2022 Q3 | -36.88 Million USD | -81.36% |
| 2021 Q4 | -133.63 Million USD | -271.51% |
| 2021 Q1 | -161.31 Million USD | -45.02% |
| 2021 FY | -396.7 Million USD | -431.63% |
| 2021 Q3 | 77.91 Million USD | 36.57% |
| 2021 Q2 | 57.05 Million USD | 135.37% |
| 2020 Q2 | -106.97 Million USD | -240.69% |
| 2020 Q1 | 76.04 Million USD | 30.89% |
| 2020 Q4 | -111.23 Million USD | -260.03% |
| 2020 Q3 | 69.5 Million USD | 164.97% |
| 2020 FY | -74.62 Million USD | -103.04% |
| 2019 Q3 | 604.41 Million CAD | 224.95% |
| 2019 FY | 2.45 Billion CAD | 17729.39% |
| 2019 Q4 | 58.09 Million CAD | -90.39% |
| 2019 Q2 | 185.99 Million CAD | -40.78% |
| 2019 Q1 | 314.09 Million CAD | 3980.46% |
| 2018 Q1 | -813.06 Thousand CAD | -149.7% |
| 2018 Q4 | -8.09 Million CAD | -45.05% |
| 2018 FY | -13.92 Million CAD | -803.1% |
| 2018 Q3 | -5.58 Million CAD | -1115.13% |
| 2018 Q2 | 549.72 Thousand CAD | 167.61% |
| 2017 Q3 | 884.29 Thousand CAD | 560.97% |
| 2017 FY | 1.98 Million CAD | 323.73% |
| 2017 Q4 | 1.63 Million CAD | 85.0% |
| 2017 Q2 | 133.78 Thousand CAD | 121.13% |
| 2017 Q1 | -633.21 Thousand CAD | -159.63% |
| 2016 Q1 | -377.59 Thousand CAD | -123.24% |
| 2016 FY | -885.4 Thousand CAD | -418.17% |
| 2016 Q4 | 1.06 Million CAD | 713.4% |
| 2016 Q3 | -173.11 Thousand CAD | 87.84% |
| 2016 Q2 | -1.42 Million CAD | -277.16% |
| 2015 Q2 | -448.55 Thousand CAD | 24.93% |
| 2015 FY | 278.27 Thousand CAD | 106.7% |
| 2015 Q4 | 1.62 Million CAD | 542.15% |
| 2015 Q3 | -367.47 Thousand CAD | 18.08% |
| 2015 Q1 | -597.52 Thousand CAD | 0.0% |
| 2014 FY | -4.15 Million CAD | -570.01% |
| 2014 Q3 | -76.68 Thousand CAD | -697.61% |
| 2014 Q2 | -9613.92 CAD | 0.0% |
| 2013 FY | -619.47 Thousand CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aurora Cannabis Inc. | -69.32 Million CAD | -6.689% |
| Avicanna Inc. | -8.74 Million CAD | -745.968% |
| Avant Brands Inc. | -5.07 Million CAD | -1358.836% |
| Cardiol Therapeutics Inc. | -28.12 Million CAD | -162.949% |
| Crescita Therapeutics Inc. | -1.98 Million CAD | -3624.22% |
| Knight Therapeutics Inc. | -16.83 Million CAD | -339.341% |
| MediPharm Labs Corp. | -13.08 Million CAD | -465.337% |
| OrganiGram Holdings Inc. | -229.47 Million CAD | 67.769% |
| Canopy Growth Corporation | -657.26 Million CAD | 88.747% |
| Willow Biosciences Inc. | -13.02 Million CAD | -467.68% |
| Auxly Cannabis Group Inc. | -44.51 Million CAD | -66.168% |